← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2002Last known activity
Apr 1, 2016
Timeline
1980s
- Jan 1, 1981
Xoma— Founded
Drugs by trial phase (11 distinct, 28 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Adenocarcinoma
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Behcet Syndrome
- Congenital Hyperinsulinism
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Ear Diseases
- Graft vs Host Disease
- Hodgkin Disease
- Hyperinsulinism
- Hypoglycemia
- Labyrinth Diseases
- Labyrinthitis
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Osteoarthritis
- Pyoderma
- Pyoderma Gangrenosum
- Uveitis
Recent trials (33)
- NCT02772718Lead sponsorPhase 2Apr 1, 2016
- NCT02772718Study directorPhase 2Apr 1, 2016
- NCT02604485Study directorPhase 2Oct 1, 2015
- NCT02604485Lead sponsorPhase 2Oct 1, 2015
- NCT02326740Lead sponsorPhase 3Dec 1, 2014
- NCT02318914Lead sponsorPhase 3Nov 1, 2014
- NCT02258867Lead sponsorPhase 3Nov 1, 2014
- NCT02315417Lead sponsorPhase 3Nov 1, 2014
- NCT02258854Lead sponsorPhase 3Mar 1, 2014
- NCT01950312Lead sponsorPhase 2Aug 1, 2013
- NCT01882491Lead sponsorPhase 2May 1, 2013
- NCT01882504Lead sponsorPhase 2May 1, 2013
- NCT02293564Lead sponsorN/AMar 1, 2013
- NCT01747538Lead sponsorPhase 3Oct 1, 2012
- NCT01684345Lead sponsorPhase 3Aug 1, 2012
Details
- Founded
- Berkeley, CA, US Jan 1, 1981
- Last known activity
- Apr 1, 2016
Notes
Aggregates royalties